APBB1IP Monoclonal Antibody
Know who made it. See the evidence. Buy through one marketplace.
APBB1IP (amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein) is a protein-coding gene. Diseases associated with APBB1IP include alzheimer's disease, and melanoma, and among its related super-pathways are p130Cas linkage to MAPK signaling for integrins and Platelet Aggregation (Plug Formation). GO annotations related to this gene include phospholipid binding. An important paralog of this gene is GRB7.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Evidence | WB | IHC-p | FCM | ELISA | IHC |
|---|---|---|---|---|---|
| Applications |
This product is manufactured by BT LAB and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
